1421314-66-0

Upstream product

• 906657-90-7 methyl 4-acetoxy-6-acetoxymethyl-5-benzyloxynicotinate 
• 906658-35-3 methyl 5-benzyloxy-6-hydroxymethyl-4-oxo-1,4-dihydropyridine-3-carboxylate 
• 140-75-0 para-fluorobenzylamine 
• 906657-89-4 methyl 4-acetoxy-5-benzyloxy-6-methyl-1-oxynicotinate 
• 100-39-0 benzyl bromide 
• 118-71-8 Maltol 
• 906657-88-3 methyl 4-acetoxy-5-benzyloxy-6-methylnicotinate 
• 1421314-65-9 methyl 5-benzyloxy-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylate 
• 1421314-64-8 3-(benzyloxy)-5-bromo-2-methylpyridin-4(1H)-one 
• 61160-18-7 3-benzyloxy-2-methyl-1H-pyridin-4-one 
• 61049-69-2 3-O-benzylmaltol 

Downstream Products

• 1421314-67-1 5-benzyloxy-N-(4-fluorobenzyl)-6-formyl-4-oxo-1,4-dihydropyridine-3-carboxamide 
• 906657-95-2 3-benzyloxy-5-(4-fluorobenzylcarbamoyl)-4-oxo-1,4-dihydropyridine-2-carboxylic acid 
• 1421314-68-2 methyl 3-benzyloxy-5-(4-fluorobenzylcarbamoyl)-4-oxo-1,4-dihydropyridine-2-carboxylate 
• 906657-97-4 methyl 1-allyl-3-benzyloxy-5-(4-fluorobenzylcarbamoyl)-4-oxo-1,4-dihydropyridine-2-carboxylate 
• 906657-98-5 methyl 3-(benzyloxy)-5-((4-fluorobengzyl)carbamoyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylate 
• 906657-99-6 9-benzyloxy-2-(2-methoxyethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazine-7-carboxylic acid 4-fluorobenzylamide 
• 906658-01-3 9-benzyloxy-2-[2-(morpholin-4-yl)ethyl]-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxylic acid 4-fluorobenzylamide 
• 906658-04-6 9-benzyloxy-2-(2-isopropoxyethyl)-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazine-7-carboxylic acid 4-fluorobenzylamide 
• 906658-22-8 9-benzyloxy-1,8-dioxo-2-(2-phenoxyethyl)-1,8-dihydro-2Hpyrido[1,2-a]pyrazine-7-carboxylic acid 4-fluorobenzylamide 
• 906658-06-8 9-benzyloxy-2-cyclohexyl-1,8-dioxo-1,8-dihydro-2H-pyrido-[1,2-a]pyrazine-7-carboxylic acid 4-fluorobenzylamide 
• 906656-31-3 C₂₂H₂₃FN₄O₅ 
• 906656-34-6 C₂₁H₂₂FN₃O₅ 
• 906656-55-1 C₂₄H₂₀FN₃O₅ 
• 906656-37-9 C₂₂H₂₂FN₃O₄ 

Relevant academic research and scientific papers

Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles

This work is a continuation of our initial discovery of a potent monocyclic carbamoyl pyridone human immunodeficiency virus type-1 (HIV-1) integrase inhibitor that displayed favorable antiviral and pharmacokinetic properties. We report herein a series of